The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

Research Article

Stirred tank bioreactor culture combined with serum‐/xenogeneic‐free culture medium enables an efficient expansion of umbilical cord‐derived mesenchymal stem/stromal cells

Amanda Mizukami

Hemotherapy Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto‐SP, Brazil

Search for more papers by this author
Ana Fernandes‐Platzgummer

Department of Bioengineering and IBB-Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal

Search for more papers by this author
Joana G. Carmelo

Department of Bioengineering and IBB-Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal

Search for more papers by this author
Kamilla Swiech

Corresponding Author

E-mail address: kamilla@fcfrp.usp.br

Hemotherapy Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto‐SP, Brazil

Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto‐SP, Brazil

Correspondence: Prof. Kamilla Swiech, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café s/n, 14040‐903, Ribeirão Preto, SP, Brazil

Additional Correspondence: Prof. Cláudia Lobato da Silva, Department of Bioengineering and IBB ‐ Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Avenida Rovisco Pais, 1049‐001 Lisboa, Portugal

Search for more papers by this author
Dimas T. Covas

Hemotherapy Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto‐SP, Brazil

Search for more papers by this author
Joaquim M. S. Cabral

Department of Bioengineering and IBB-Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal

Search for more papers by this author
Cláudia L. da Silva

Corresponding Author

E-mail address: claudia_lobato@tecnico.ulisboa.pt

Department of Bioengineering and IBB-Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal

Correspondence: Prof. Kamilla Swiech, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café s/n, 14040‐903, Ribeirão Preto, SP, Brazil

Additional Correspondence: Prof. Cláudia Lobato da Silva, Department of Bioengineering and IBB ‐ Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Avenida Rovisco Pais, 1049‐001 Lisboa, Portugal

Search for more papers by this author
First published: 11 May 2016
Cited by: 11

Abstract

Mesenchymal stem/stromal cells (MSC) are being widely explored as promising candidates for cell‐based therapies. Among the different human MSC origins exploited, umbilical cord represents an attractive and readily available source of MSC that involves a non‐invasive collection procedure. In order to achieve relevant cell numbers of human MSC for clinical applications, it is crucial to develop scalable culture systems that allow bioprocess control and monitoring, combined with the use of serum/xenogeneic (xeno)‐free culture media. In the present study, we firstly established a spinner flask culture system combining gelatin‐based Cultispher®S microcarriers and xeno‐free culture medium for the expansion of umbilical cord matrix (UCM)‐derived MSC. This system enabled the production of 2.4 (±1.1) x105 cells/mL (n = 4) after 5 days of culture, corresponding to a 5.3 (±1.6)‐fold increase in cell number. The established protocol was then implemented in a stirred‐tank bioreactor (800 mL working volume) (n = 3) yielding 115 million cells after 4 days. Upon expansion under stirred conditions, cells retained their differentiation ability and immunomodulatory potential. The development of a scalable microcarrier‐based stirred culture system, using xeno‐free culture medium that suits the intrinsic features of UCM‐derived MSC represents an important step towards a GMP compliant large‐scale production platform for these promising cell therapy candidates.

Number of times cited according to CrossRef: 11

  • , A Fully-Closed and Automated Hollow Fiber Bioreactor for Clinical-Grade Manufacturing of Human Mesenchymal Stem/Stromal Cells, Stem Cell Reviews and Reports, 14, 1, (141), (2018).
  • , Aggregation of culture expanded human mesenchymal stem cells in microcarrier-based bioreactor, Biochemical Engineering Journal, 10.1016/j.bej.2017.12.011, 131, (39-46), (2018).
  • , Off-the-Shelf Mesenchymal Stem Cell Technology, Stem Cell Drugs - A New Generation of Biopharmaceuticals, 10.1007/978-3-319-99328-7_7, (119-141), (2018).
  • , Technologies for large-scale umbilical cord-derived MSC expansion: Experimental performance and cost of goods analysis, Biochemical Engineering Journal, 10.1016/j.bej.2018.02.018, 135, (36-48), (2018).
  • , The Challenge of Human Mesenchymal Stromal Cell Expansion: Current and Prospective Answers, New Insights into Cell Culture Technology, 10.5772/66901, (2017).
  • , Application of Bioreactor in Stem Cell Culture, Journal of Biomedical Science and Engineering, 10.4236/jbise.2017.1011037, 10, 11, (485-499), (2017).
  • , Allogeneic cell therapy manufacturing: process development technologies and facility design options, Expert Opinion on Biological Therapy, 10.1080/14712598.2017.1354982, 17, 10, (1201-1219), (2017).
  • , Expansion strategies for human mesenchymal stromal cells culture under xeno‐free conditions, Biotechnology Progress, 33, 5, (1358-1367), (2017).
  • , Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells, Journal of Biotechnology, 10.1016/j.jbiotec.2016.08.007, 236, (88-109), (2016).
  • , Silk/Fibroin Microcarriers for Mesenchymal Stem Cell Delivery: Optimization of Cell Seeding by the Design of Experiment, Pharmaceutics, 10.3390/pharmaceutics10040200, 10, 4, (200), (2018).
  • , Mesenchymal stem cell cultivation in electrospun scaffolds: mechanistic modeling for tissue engineering, Journal of Biological Physics, 10.1007/s10867-018-9482-y, (2018).